Prostate cancer (PCa) is the leading cancer in men globally. The association between PCa
and long non-coding RNAs (lncRNAs) has been reported. Aberrantly expressed lncRNAs …

Long non-coding RNAs (lncRNAs) are regulatory transcripts with essential roles in the
pathogenesis of almost all types of cancers, including prostate cancer. They can act as …

Prostate cancer (PCa) is the second lethal disease for men in western countries. Although
androgen receptor (AR) signaling has been widely investigated, noncoding RNAs …

Despite advancements, prostate cancers (PCa) are a significant global health due to
delayed diagnosis and therapeutic resistance. This review delves into the complex …

The importance of long non-coding RNAs (lncRNAs) in the pathogenesis of various
malignancies has been uncovered over the last few years. Their dysregulation often …

Whole genome transcriptomic analyses have identified a large number of long non-coding
RNAs (lncRNAs), many of which are involved in a variety of biological functions. However …

In the entire world, prostate cancer (PCa) is one of the most common and deadly cancers.
Treatment failure is still common among patients, despite PCa diagnosis and treatment …

Prostate cancer (PCa) is a leading cause of mortality among males. Long non-coding RNAs
(lncRNAs) are subclass of noncoding RNAs that may act as biomarkers and therapeutic …

Background One of the most malignant tumors in men is prostate cancer that is still incurable
due to its heterogenous and progressive natures. Genetic and epigenetic changes play …

Recent transcriptome studies using next-generation sequencing have detected aberrant
changes in the expression of noncoding RNAs (ncRNAs) associated with cancer. For …